Suppr超能文献

印度中部地区人类免疫缺陷病毒相关神经认知缺陷的横断面研究

A Cross-Sectional Study of Human Immunodeficiency Virus-Associated Neurocognitive Deficit in Central India.

作者信息

Maitra Dr Saptarshi, Motlag Mrinalini

机构信息

Internal Medicine, Indira Gandhi Government Medical College, Nagpur, IND.

出版信息

Cureus. 2021 Oct 14;13(10):e18776. doi: 10.7759/cureus.18776. eCollection 2021 Oct.

Abstract

Background With the advent of modern era of combination antiretroviral therapy (cART) and increased longevity of people living with human immunodeficiency virus (PLHIV), human immunodeficiency virus-associated neurocognitive disorder (HAND) is commonly observed. This study explores the prevalence of HAND and the demographic and treatment variables in people with HAND, in Central India. Research methodology PLHIV on cART visiting HIV clinic underwent screening for substance abuse using CAGE-AID, and depression using PHQ-2 followed by PHQ-9. The screening rules out overt conditions which might interfere with cognitive abilities of the individual and thereby act as confounding factor. Thus, a sample population of 96 was obtained, on whom International HIV Dementia Scale (IHDS) was applied to screen for dementia. Out of 96, 16 individuals detected to suffer from HAND. Quality of Life was assessed by Patient's Assessment of Own Functioning Inventory (PAOFI). Results Prevalence of HAND was estimated to be 16/96 (16.66%). It was more common amongst unmarried individuals (p < 0.001) and lower educational status (p < 0.01) among social variables; while shorter duration of ART (<3 years) (p < 0.01) and lower CD4 nadir (≤200 cell/mm; p<0.01) showed significant correlation among clinical variables. PAOFI revealed significant association between HAND and quality of life (p-value < 0.01, CI = 95%). Modified Mental State Examination (3MS), which determines cognitive ability in various domains based on tasks, was mostly affected for - similarities and read and obey (for 43.75% population). Conclusion Social and clinical variables play a significant role in development of HAND. Routine screening for HAND in PLHIV will help in early identification and management of the disease. The quality of life for those suffering from the burden of HIV and HAND can be significantly improved if approached and treated early in the course of the disease.

摘要

背景 随着现代联合抗逆转录病毒疗法(cART)时代的到来以及人类免疫缺陷病毒(HIV)感染者寿命的延长,人类免疫缺陷病毒相关神经认知障碍(HAND)已较为常见。本研究探讨印度中部HAND的患病率以及HAND患者的人口统计学和治疗变量。

研究方法 接受cART治疗且前往HIV诊所就诊的HIV感染者使用CAGE-AID进行药物滥用筛查,并使用PHQ-2随后使用PHQ-9进行抑郁筛查。该筛查排除了可能干扰个体认知能力从而成为混杂因素的明显病症。因此,获得了96名样本人群,并对其应用国际HIV痴呆量表(IHDS)进行痴呆筛查。在96人中,有16人被检测出患有HAND。通过患者自我功能评估量表(PAOFI)评估生活质量。

结果 HAND的患病率估计为16/96(16.66%)。在社会变量中,未婚个体(p < 0.001)和低教育水平(p < 0.01)中更为常见;而在临床变量中,抗逆转录病毒治疗时间较短(<3年)(p < 0.01)和最低CD4计数较低(≤200个细胞/mm³;p < 0.01)显示出显著相关性。PAOFI显示HAND与生活质量之间存在显著关联(p值< 0.01,CI = 95%)。基于任务确定各个领域认知能力的改良精神状态检查(3MS)在相似性以及阅读和服从方面受影响最大(占43.75%的人群)。

结论 社会和临床变量在HAND的发生中起重要作用。对HIV感染者进行HAND的常规筛查将有助于疾病的早期识别和管理。如果在疾病过程中尽早发现并治疗,那些承受HIV和HAND负担的人的生活质量可以得到显著改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6a3/8590455/4c019295296f/cureus-0013-00000018776-i01.jpg

相似文献

1
A Cross-Sectional Study of Human Immunodeficiency Virus-Associated Neurocognitive Deficit in Central India.
Cureus. 2021 Oct 14;13(10):e18776. doi: 10.7759/cureus.18776. eCollection 2021 Oct.
2
Is International HIV Dementia Scale good enough to diagnose HIV-associated neurocognitive disorders?
J Family Med Prim Care. 2022 Sep;11(9):5060-5064. doi: 10.4103/jfmpc.jfmpc_356_21. Epub 2022 Oct 14.
3
Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
BMC Infect Dis. 2019 Feb 13;19(1):156. doi: 10.1186/s12879-019-3784-y.
4
Determining the Neurocognitive Status and the Functional Ability of Patients to Screen for HIV-Associated Neurocognitive Disorder (HAND).
Dement Neurocogn Disord. 2020 Mar;19(1):19-27. doi: 10.12779/dnd.2020.19.1.19. Epub 2019 Dec 24.
5
Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.
Neurol Res Int. 2019 Oct 30;2019:5173289. doi: 10.1155/2019/5173289. eCollection 2019.
6
Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.
Rev Soc Bras Med Trop. 2015 Jul-Aug;48(4):390-8. doi: 10.1590/0037-8682-0034-2015.
7
Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
AIDS Patient Care STDS. 2018 Jan;32(1):1-8. doi: 10.1089/apc.2017.0202.
10
HIV-associated neurocognitive disorders at Moi teaching and referral hospital, Eldoret, Kenya.
BMC Neurol. 2020 Jul 14;20(1):280. doi: 10.1186/s12883-020-01857-3.

本文引用的文献

2
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.
Nat Rev Neurol. 2016 Apr;12(4):234-48. doi: 10.1038/nrneurol.2016.27. Epub 2016 Mar 11.
3
Prevalence of HIV-Associated Neurocognitive Disorder (HAND) among Patients Attending a Tertiary Health Facility in Northern Nigeria.
J Int Assoc Provid AIDS Care. 2017 Jan/Feb;16(1):48-55. doi: 10.1177/2325957414553839. Epub 2016 Jun 23.
4
Cohort Profile: Recruitment cohorts in the neuropsychological substudy of the Multicenter AIDS Cohort Study.
Int J Epidemiol. 2015 Oct;44(5):1506-16. doi: 10.1093/ije/dyu092. Epub 2014 Apr 24.
5
Diagnostic accuracy of the International HIV Dementia Scale and HIV Dementia Scale: A meta-analysis.
Exp Ther Med. 2012 Oct;4(4):665-668. doi: 10.3892/etm.2012.665. Epub 2012 Aug 14.
8
HIV-1 infection and cognitive impairment in the cART era: a review.
AIDS. 2011 Mar 13;25(5):561-75. doi: 10.1097/QAD.0b013e3283437f9a.
9
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.
Neurology. 2010 Dec 7;75(23):2087-96. doi: 10.1212/WNL.0b013e318200d727.
10
Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.
J Neurol Sci. 2009 Oct 15;285(1-2):149-53. doi: 10.1016/j.jns.2009.06.043. Epub 2009 Jul 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验